Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $8.15B | $7.45B | +9.43% |
Cost of Revenue | $2.97B | $3.2B | -7.25% |
Operating Income | $1.18B | $991M | +18.87% |
Net Income | $1.73B | $-113M | +1630.97% |
EPS (Basic) | $3.22 | $-0.21 | +1633.33% |
EPS (Diluted) | $3.20 | $-0.21 | +1623.81% |
SG&A Expense | $1.69B | $1.81B | -6.69% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $89.37B | $92.98B | -3.89% |
Current Assets | $26.93B | $28.03B | -3.92% |
Current Liabilities | $23.01B | $19.71B | +16.71% |
Stockholders' Equity | $6.21B | $5.02B | +23.60% |
Cash & Equivalents | $8.81B | $9.71B | -9.25% |
Long-Term Debt | $57.38B | $64.02B | -10.37% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.39B | $689M | +101.89% |
Investing Cash Flow | $-447M | $-217M | -105.99% |
Financing Cash Flow | $-4.11B | $-1.71B | -140.46% |
D&A | $1.39B | $1.4B | -0.86% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 14.5% | 13.3% | +1.15% |
Net Margin | 21.2% | — | — |
ROE | 27.9% | — | — |
ROA | 1.9% | — | — |
Current Ratio | $1.17 | — | — |
Other companies in Biotechnology